日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity

USP13 通过改变肺棒状细胞谱系可塑性来驱动肺鳞状细胞癌

Juntae Kwon, Jinmin Zhang, Boram Mok, Samuel Allsup, Chul Kim, Jeffrey Toretsky, Cecil Han

Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response

靶向 DDX3X 通过 dsRNA 介导的肿瘤内在 I 型干扰素反应触发抗肿瘤免疫

Hyeongjwa Choi, Juntae Kwon, Min Soon Cho, Yifan Sun, Xiaofeng Zheng, Jing Wang, Kerrie B Bouker, John L Casey, Michael B Atkins, Jeffrey Toretsky, Cecil Han

Development of an Ewing sarcoma cell line with resistance to EWS‑FLI1 inhibitor YK‑4‑279

开发对 EWS-FLI1 抑制剂 YK-4-279 具有抗性的尤文氏肉瘤细胞系

Erin Conn, Sarah Hour, David Allegakoen, Garrett Graham, Jeff Petro, Marilyn Kouassi-Brou, Sung Hyeok Hong, Saravana Selvanathan, Haydar Çelik, Jeffrey Toretsky, Aykut Üren

Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers

鉴定 EWS-FLI1 的可用药物相互作用组揭示了尤文氏肉瘤细胞对凋亡诱导剂的 MCL-1 依赖性差异敏感性

Kalliopi Tsafou, Anna Maria Katschnig, Branka Radic-Sarikas, Cornelia Noëlle Mutz, Kristiina Iljin, Raphaela Schwentner, Maximilian O Kauer, Karin Mühlbacher, Dave N T Aryee, David Westergaard, Saija Haapa-Paananen, Vidal Fey, Giulio Superti-Furga, Jeffrey Toretsky, Søren Brunak, Heinrich Kovar

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model

YK-4-279 可有效拮抗转基因小鼠模型中 EWS-FLI1 诱发的白血病

Tsion Zewdu Minas, Jenny Han, Tahereh Javaheri, Sung-Hyeok Hong, Michaela Schlederer, Yasemin Saygideğer-Kont, Haydar Çelik, Kristina M Mueller, Idil Temel, Metin Özdemirli, Heinrich Kovar, Hayriye Verda Erkizan, Jeffrey Toretsky, Lukas Kenner, Richard Moriggl, Aykut Üren

Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma

尤文氏肉瘤中 EWS-FLI1 相互作用的小分子干扰物的合成及构效关系研究

Perrer N Tosso, Yali Kong, Lauren Scher, Ryan Cummins, Jeffrey Schneider, Said Rahim, K Travis Holman, Jeffrey Toretsky, Kan Wang, Aykut Üren, Milton L Brown

Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma

突变型 KRAS 的下游,转录调节因子 YAP 对胰腺导管腺癌的肿瘤进展至关重要

Weiying Zhang, Nivedita Nandakumar, Yuhao Shi, Mark Manzano, Alias Smith, Garrett Graham, Swati Gupta, Eveline E Vietsch, Sean Z Laughlin, Mandheer Wadhwa, Mahandranauth Chetram, Mrinmayi Joshi, Fen Wang, Bhaskar Kallakury, Jeffrey Toretsky, Anton Wellstein, Chunling Yi

Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature

胰岛素样生长因子 1 受体作为尤文氏肉瘤的治疗靶点:缺乏一致的上调或复发性突变以及临床试验文献的回顾

Alison O'Neill, Nilay Shah, Naamah Zitomersky, Marc Ladanyi, Neerav Shukla, Aykut Uren, David Loeb, Jeffrey Toretsky

Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells

荧光肌球蛋白轻链磷酸酶抑制剂对前列腺癌细胞的影响

Scott Grindrod, Simeng Suy, Shannon Fallen, Masumi Eto, Jeffrey Toretsky, Milton L Brown